tradingkey.logo

tradingkey.logo
怜玢


Immunoprecise Antibodies Ltd

IPA
2.070USD
0.0000.00%
終倀 03/30, 16:00ET15分遅れの株䟡
95.54M時䟡総額
損倱額盎近12ヶ月PER


Immunoprecise Antibodies Ltd

2.070
0.0000.00%

詳现情報 Immunoprecise Antibodies Ltd 䌁業名

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.

Immunoprecise Antibodies Ltdの䌁業情報


䌁業コヌドIPA
䌚瀟名Immunoprecise Antibodies Ltd
䞊堎日Jan 30, 1987
最高経営責任者「CEO」Dr. Jennifer Lynne Bath, Ph.D.
埓業員数- -
蚌刞皮類Ordinary Share
決算期末Jan 30
本瀟所圚地Industrious 823 Congress Ave Suite 300
郜垂AUSTIN
蚌刞取匕所NASDAQ Capital Market Consolidated
囜United States of America
郵䟿番号78701
電話番号16048060626
りェブサむトhttps://www.ipatherapeutics.com/
䌁業コヌドIPA
䞊堎日Jan 30, 1987
最高経営責任者「CEO」Dr. Jennifer Lynne Bath, Ph.D.

Immunoprecise Antibodies Ltdの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Shuji Sato
Dr. Shuji Sato
Vice President - Innovative Solutions
Vice President - Innovative Solutions
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
事業別USD
䌚瀟名
収益
比率
Project revenue
4.06M
98.40%
Cryo storage revenue
66.00K
1.60%
Product sales revenue
0.00
0.00%
地域別USD
䌚瀟名
収益
比率
United States of America
2.40M
58.20%
Europe
900.00K
21.82%
Other
550.00K
13.34%
Australia
226.00K
5.48%
Canada
48.00K
1.16%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Project revenue
4.06M
98.40%
Cryo storage revenue
66.00K
1.60%
Product sales revenue
0.00
0.00%

株䞻

曎新時刻: Wed, Feb 25
曎新時刻: Wed, Feb 25
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Charmquark TWEE
7.83%
Ingalls & Snyder LLC (Asset Management)
5.84%
Susquehanna International Group, LLP
1.14%
Bath (Jennifer Lynne)
1.07%
Renaissance Technologies LLC
0.51%
他の
83.62%
株䞻統蚈
株䞻統蚈
比率
Charmquark TWEE
7.83%
Ingalls & Snyder LLC (Asset Management)
5.84%
Susquehanna International Group, LLP
1.14%
Bath (Jennifer Lynne)
1.07%
Renaissance Technologies LLC
0.51%
他の
83.62%
皮類
株䞻統蚈
比率
Corporation
7.83%
Investment Advisor/Hedge Fund
6.29%
Investment Advisor
1.53%
Individual Investor
1.23%
Hedge Fund
0.99%
Research Firm
0.65%
Venture Capital
0.17%
Bank and Trust
0.07%
他の
81.24%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
48
4.07M
8.72%
-243.01K
2025Q3
41
3.90M
8.45%
-302.90K
2025Q2
46
8.16M
23.11%
+1.40M
2025Q1
45
6.32M
13.81%
+742.61K
2024Q4
45
4.34M
9.53%
-1.30M
2024Q3
46
5.39M
19.68%
+72.87K
2024Q2
48
5.12M
19.96%
-156.62K
2024Q1
50
5.14M
20.20%
-196.19K
2023Q4
58
5.33M
20.96%
+124.72K
2023Q3
50
4.91M
19.67%
-438.42K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Charmquark TWEE
3.66M
7.83%
--
--
Jul 25, 2025
Ingalls & Snyder LLC (Asset Management)
2.70M
5.78%
-79.67K
-2.87%
Sep 30, 2025
Susquehanna International Group, LLP
501.70K
1.07%
-197.54K
-28.25%
Sep 30, 2025
Bath (Jennifer Lynne)
498.12K
1.07%
--
--
Aug 27, 2025
Renaissance Technologies LLC
220.48K
0.47%
+180.00K
+444.66%
Sep 30, 2025
Jane Street Capital, L.L.C.
23.78K
0.05%
+13.04K
+121.45%
Sep 30, 2025
Marshall Wace LLP
168.65K
0.36%
+168.65K
--
Sep 30, 2025
Two Sigma Investments, LP
108.93K
0.23%
+18.08K
+19.90%
Sep 30, 2025
XTX Markets LLC
37.39K
0.08%
-53.99K
-59.08%
Sep 30, 2025
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™